Stock 002932 WUHAN EASY DIAGNOSIS BIOMEDICINE CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Wuhan Easy Diagnosis Biomedicine Co.,Ltd.

Equities

002932

CNE1000033Q7

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
20.79 CNY +1.81% Intraday chart for Wuhan Easy Diagnosis Biomedicine Co.,Ltd. +6.13% -9.49%
Apr. 01 Tranche Update on Wuhan Easy Diagnosis Biomedicine Co.,Ltd.'s Equity Buyback Plan announced on March 28, 2024. CI
Mar. 27 Wuhan Easy Diagnosis Biomedicine Co.,Ltd. commences an Equity Buyback Plan for CNY 350 million worth of its shares, under the authorization approved on March 18, 2024. CI

Business Summary

Wuhan Easy Diagnosis Biomedicine Co., Ltd. is a China-based company which is mainly engaged in research and development, manufacture and sales of Point of Care Testing (POCT) rapid diagnostic reagents and quick testing instruments. The Company's main products are POCT rapid diagnostic reagents, which can be divided into six categories: infectious diseases, cardiovascular and cerebrovascular diseases, kidney diseases, diabetes, gynecology and eugenics, and health checkups. The Company's main products are mainly used in domestic hospitals, health service centers, community clinics, medical examination centers and other medical institutions.

Number of employees: 1,547

Sales per Business

CNY in Million2022Weight2023Weight Delta
In Vitro Diagnostic Reagents
52.5 %
9,779 92.9 % 393 52.5 % -95.98%
Third-party Medical Test
39.8 %
422 4.0 % 298 39.8 % -29.35%
Agent
7.8 %
137 1.3 % 58 7.8 % -57.57%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
98.6 %
10,232 97.2 % 739 98.6 % -92.78%
Overseas
1.4 %
298 2.8 % 11 1.4 % -96.39%

Managers

Managers TitleAgeSince
Li Li Chen CEO
 Chief Executive Officer 50 13-10-22
Guo Hui Zhou DFI
 Director of Finance/CFO 40 21-08-17
Ying Wang BRD
 Director/Board Member - 13-10-30
Bo Xu IRC
 Investor Relations Contact - -
Rui Wang SEC
 Corporate Secretary 46 18-07-17

Members of the board

Members of the board TitleAgeSince
Jin Cheng Xie BRD
 Director/Board Member 63 21-11-25
Xian Wang Shi BRD
 Director/Board Member 56 22-10-20
Li Li Chen CEO
 Chief Executive Officer 50 13-10-22
Ying Wang BRD
 Director/Board Member - 13-10-30
Jian Fei Wang BRD
 Director/Board Member 48 15-02-12
Zhen Lu Zhang BRD
 Director/Board Member 61 19-10-22
Yi Quan BRD
 Director/Board Member 38 21-11-25
Han Ling Yang CHM
 Chairman 42 22-10-20
Jin Bo Chao BRD
 Director/Board Member 34 19-10-22
You Wen Zhao BRD
 Director/Board Member 36 15-12-29

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 232,520,957 117,627,183 ( 50.59 %) 1,272,452 ( 0.5472 %) 50.59 %

Shareholders

NameEquities%Valuation
Li Li Chen
10.22 %
15,729,724 10.22 % 47 M ¥
Ying Wang
5.835 %
8,979,227 5.835 % 27 M ¥
Maxwealth Fund Management Co., Ltd.
0.2999 %
461,464 0.2999 % 1 M ¥
Rui Wang
0.2336 %
359,416 0.2336 % 1 M ¥
Fullgoal Fund Management Co., Ltd.
0.1986 %
305,655 0.1986 % 921 094 ¥
Ping An Fund Management Co., Ltd.
0.1833 %
282,077 0.1833 % 850 042 ¥
China Asset Management Co., Ltd.
0.1622 %
249,588 0.1622 % 752 136 ¥
China Southern Asset Management Co., Ltd.
0.1412 %
217,221 0.1412 % 654 598 ¥
Hwabao WP Fund Management Co., Ltd.
0.1367 %
210,320 0.1367 % 633 801 ¥
Bosera Asset Management Co., Ltd.
0.0829 %
127,520 0.0829 % 384 283 ¥
NameEquities%Valuation
Li Li Chen
60.11 %
47,189,170 60.11 % 142 M ¥
Ying Wang
34.31 %
26,937,679 34.31 % 81 M ¥
Rui Wang
3.397 %
2,666,729 3.397 % 8 M ¥

Company contact information

Wuhan Easy Diagnosis Biomedicine Co., Ltd.

Room 1, 1/F, Building 22 388 Gaoxin 2nd Road

430075, Wuhan

+86 27 6552 3649

http://www.mdeasydiagnosis.com
address Wuhan Easy Diagnosis Biomedicine Co.,Ltd.(002932)

Sector

Healthcare
Healthcare Services
Healthcare Equipment & Supplies
Medical Equipment, Supplies & Distribution
Diagnostic & Testing Substances

Sales per Business

Sales per region

Sector Diagnostic & Testing Substances

1st Jan change Capi.
WUHAN EASY DIAGNOSIS BIOMEDICINE CO.,LTD. Stock Wuhan Easy Diagnosis Biomedicine Co.,Ltd.
-9.49% 668M
BIOMÉRIEUX Stock bioMérieux
-1.89% 12.56B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD. Stock Shenzhen New Industries Biomedical Engineering Co., Ltd.
-9.59% 7.68B
DIASORIN S.P.A. Stock DiaSorin S.p.A.
-1.31% 5.29B
LANTHEUS HOLDINGS, INC. Stock Lantheus Holdings, Inc.
+21.82% 5.18B
AUTOBIO DIAGNOSTICS CO., LTD. Stock Autobio Diagnostics Co., Ltd.
+0.02% 4.57B
10X GENOMICS, INC. Stock 10x Genomics, Inc.
-50.89% 3.29B
ANDON HEALTH CO., LTD. Stock Andon Health Co., Ltd.
+6.42% 2.6B
VITROLIFE AB Stock Vitrolife AB
-10.02% 2.2B
GUANGZHOU WONDFO BIOTECH CO.,LTD Stock Guangzhou Wondfo Biotech Co.,Ltd
-8.29% 1.79B
Diagnostic & Testing Substances
  1. Stock Market
  2. Equities
  3. 002932 Stock
  4. Company Wuhan Easy Diagnosis Biomedicine Co.,Ltd.